[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100544992":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":19,"responsibleParty":37,"collaborators":7,"id":39,"slug":7,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":7,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"AstraZeneca","INDUSTRY",null,[9],{"name":10,"affiliation":11,"role":12},"Erica N Hasimoto","Hospital das Clínicas da Faculdade de Medicina de Botucatu (HCFMB)","PRINCIPAL_INVESTIGATOR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"AstraZeneca Clinical Study Information Center","CONTACT","1-877-240-9479","information.center@astrazeneca.com",[20],{"facility":11,"status":21,"city":22,"state":23,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"RECRUITING","Botucatu","São Paulo","18618-686","Brazil",{"type":27,"coordinates":28},"Point",[29,30],-48.445,-22.88583,{"lat":30,"lon":29},[33],{"name":34,"role":16,"phone":35,"phoneExt":7,"email":36},"Erica Hasimoto","(14) 99792-0222","ericanh80@hotmail.com",{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100544992",false,"NCT06376097","Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.","Implementation of a Lung Cancer Screening Program in a Public Service, Using Low-dose Tomography and Metabolomics Evaluation","Inclusion Criteria:\n\nAge between 45 and 74 years old; Smoker with a smoking history of at least 30 pack-years or former smoker who has quit smoking for less than 15 years; Never having participated in a lung cancer screening program ; Signing of the free and informed consent form.\n\nExclusion Criteria:\n\nPatients with chronic diseases (cardiovascular, pulmonary, hepatic, renal or metabolic) at an advanced stage that limit life expectancy or make it impossible to perform a curative surgical procedure; Patients being treated for tuberculosis or other granulomatous diseases; Patients diagnosed with previous neoplasm(s) that could develop lung metastases; Pregnant women; Patients who, for some reason, are unable to undergo low-dose chest computed tomography; Patients previously submitted to thoracic radiotherapy.","ALL","45 Years","74 Years",{"count":49,"type":50},1000,"ESTIMATED","OBSERVATIONAL","Observational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.",[54],"Lung Cancer",[56],"Observational; Lung Cancer; Screening;","2026-06-17",{"date":59,"type":60},"2026-06-18","ACTUAL",{"date":62,"type":60},"2023-04-19",{"date":64,"type":50},"2026-06-29",{"name":5,"class":6},1]